Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
European Pharmaceutical Journal
Volume 59 (2012): Issue Supplement-VI (January 2012)
Open Access
Orphan drugs used for treatment in pediatric patients in the slovak republic
T. Foltánová
T. Foltánová
,
M. Konečný
M. Konečný
,
A. Hlavatá
A. Hlavatá
,
K. Štepánková
K. Štepánková
and
F. Cisárik
F. Cisárik
| Jun 19, 2012
European Pharmaceutical Journal
Volume 59 (2012): Issue Supplement-VI (January 2012)
Clinical Pharmacy in the Slovak Republic, dedicated to the associated professor Lívia Magulová, PhD.
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Jun 19, 2012
Page range:
28 - 34
DOI:
https://doi.org/10.2478/v10219-012-0001-0
Keywords
Orphan drugs
,
Paediatric regulation
,
Availability
,
Accessibility
This content is open access.
T. Foltánová
Faculty of Pharmacy, Department of Pharmacology and Toxicology, Comenius University in Bratislava
M. Konečný
Department of Clinical Genetics, St. Elizabeth Cancer Institute, Bratislava
A. Hlavatá
2Department of Pediatrics, UniversityChildren's Hospital, Bratislava
K. Štepánková
Slovak Cystic Fibrosis Association, Košice
F. Cisárik
Department of Medical Genetics, Faculty Hospital, Žilina